Explore
Validate
Learn
Western blot
ELISAAntibody data
- Antibody Data
- Antigen structure
- References [4]
- Comments [0]
- Validations
- Western blot [1]
- Immunohistochemistry [2]
Submit
Validation data
Reference
Comment
Report error
- Product number
- 13402-1-AP - Provider product page
- Provider
- Proteintech Group
- Proper citation
- Proteintech Cat#13402-1-AP, RRID:AB_10640425
- Product name
- CHD9 antibody
- Antibody type
- Polyclonal
- Description
- KD/KO validated CHD9 antibody (Cat. #13402-1-AP) is a rabbit polyclonal antibody that shows reactivity with human, mouse, rat and has been validated for the following applications: IF, IHC, WB,ELISA.
- Reactivity
- Human, Mouse, Rat
- Host
- Rabbit
- Conjugate
- Unconjugated
- Isotype
- IgG
- Vial size
- 20ul, 150ul
Submitted references A Two-Color Haploid Genetic Screen Identifies Novel Host Factors Involved in HIV-1 Latency.
High CHD9 expression is associated with poor prognosis in clear cell renal cell carcinoma.
Decreased expression of chromodomain helicase DNA-binding protein 9 is a novel independent prognostic biomarker for colorectal cancer.
miR-200c-3p spreads invasive capacity in human oral squamous cell carcinoma microenvironment.
Röling M, Mollapour Sisakht M, Ne E, Moulos P, Crespo R, Stoszko M, De Crignis E, Bodmer H, Kan TW, Akbarzadeh M, Harokopos V, Hatzis P, Palstra RJ, Mahmoudi T
mBio 2021 Dec 21;12(6):e0298021
mBio 2021 Dec 21;12(6):e0298021
High CHD9 expression is associated with poor prognosis in clear cell renal cell carcinoma.
Guan B, Ran XG, Du YQ, Ren F, Tian Y, Wang Y, Chen MM
International journal of clinical and experimental pathology 2018;11(7):3697-3702
International journal of clinical and experimental pathology 2018;11(7):3697-3702
Decreased expression of chromodomain helicase DNA-binding protein 9 is a novel independent prognostic biomarker for colorectal cancer.
Xu L, Peng H, Huang XX, Xia YB, Hu KF, Zhang ZM
Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas 2018 Jul 23;51(9):e7588
Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas 2018 Jul 23;51(9):e7588
miR-200c-3p spreads invasive capacity in human oral squamous cell carcinoma microenvironment.
Kawakubo-Yasukochi T, Morioka M, Hazekawa M, Yasukochi A, Nishinakagawa T, Ono K, Kawano S, Nakamura S, Nakashima M
Molecular carcinogenesis 2018 Feb;57(2):295-302
Molecular carcinogenesis 2018 Feb;57(2):295-302
No comments: Submit comment
Supportive validation
- Submitted by
- Proteintech Group (provider)
- Main image
- Experimental details
- human brain tissue were subjected to SDS PAGE followed by western blot with 13402-1-AP(CHD9 antibody) at dilution of 1:300
- Sample type
- tissue
Supportive validation
- Submitted by
- Proteintech Group (provider)
- Main image
- Experimental details
- Immunohistochemical of paraffin-embedded human kidney using 13402-1-AP(CHD9 antibody) at dilution of 1:100 (under 10x lens)
- Sample type
- tissue
- Submitted by
- Proteintech Group (provider)
- Main image
- Experimental details
- The CHD9 antibody from Proteintech is a rabbit polyclonal antibody to a recombinant protein of human CHD9. This antibody recognizes human, mouse, rat antigen. The CHD9 antibody has been validated for the following applications: ELISA, WB, IHC analysis.
